ABP1019A
/ AB Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
April 23, 2025
A phase I clinical trial of ABP1019A monotherapy in patients with advanced malignant solid tumors.
(ASCO 2025)
- P1 | "Clinical Trial Registration Number: ChiCTR2400081035 The abstract will be released to the public on May 22, 2025 at 4:00 PM CDT"
Clinical • Metastases • Monotherapy • P1 data • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1